(Q37825652)

23 August 2017

1 reference

title

Hepatitis C virus: How genetic variability affects pathobiology of disease (English)

1 reference

23 August 2017

1 reference

1 reference

1

Kazuaki Chayama

1 reference

23 August 2017

2

C Nelson Hayes

1 reference

23 August 2017

1 January 2011

1 reference

Journal of Gastroenterology and Hepatology

23 August 2017

1 reference

23 August 2017

26 Suppl 1

1 reference

23 August 2017

83-95

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06550.X

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06550.X

Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06550.X

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06550.X

Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06550.X

10.1111/J.1440-1746.2010.06550.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21199518